contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


demant-as-opdateret-tidsplan-for-evalueringen-af-strategiske-muligheder-for-communications

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Demant is a medical technology company. The company specializes in the development of hearing aids and hearing loops. The company operates worldwide, and the products are sold under various brands. The products are accessed via the company's distributors and sales channels. In addition to its main operations, the company conducts research in diagnostics for measuring hearing quality. The company was originally founded in 1904 and is headquartered in Smörum. 

Demant

26.6.2024 08:06:25 CEST | Demant A/S | Intern videnSelskabsmeddelelse nr. 2024-09 26. juni 2024Opdateret tidsplan for evalueringen af strategiske muligheder for Communications Som meldt ud den...

26.6.2024 08:06:25 CEST | Demant A/S | Intern videnSelskabsmeddelelse nr. 2024-09&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26. juni 2024Opdateret tidsplan for evalueringen af strategiske muligheder for Communications&nbsp;Som meldt ud den 5. februar 2024 er Demant i gang med at evaluere de strategiske muligheder for koncernens Communications-forretning, der udvikler premium audio- og videoløsninger til virksomheder under EPOS-brandet. Evalueringen pågår stadig, og vi forventer nu, at den vil være afsluttet i Q3 2024 (tidligere ved udgangen af H1 2024). I mellemtiden forbliver vi fuldt ud dedikeret til at drive forretningen og betjene vores kunder og partnere som hidtil.&nbsp;Som tidligere kommunikeret vil yderligere information om fremdriften i evalueringsprocessen blive offentliggjort, når og hvis det er påkrævet.&nbsp;&nbsp;<table class="prs-table"><tbody><tr><td>Yderligere information:Søren Nielsen, koncernchef og adm. direktørTelefon +45 3917 7300<a href="http://www.demant.com">www.demant.com</a></td><td>Øvrige kontaktpersoner:René Schneider, CFOPeter Pudselykke, Head of Investor RelationsHenrik Axel Lynge Buchter, Manager of External Communications</td></tr></tbody></table>&nbsp;&nbsp;<h4>Kontakter</h4><ul> <li> Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication &amp; Sustainability, +45 2264 9982, <a href="mailto:heey@demant.com">heey@demant.com</a> </li></ul><h4>Om Demant A/S</h4>Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.<h4>Vedhæftninger</h4><ul> <li> <a href="https://via.ritzau.dk/ir-files/13560112/13932258/13590/2024-09%20Opdateret%20tidsplan%20for%20evaluering%20af%20strategiske%20muligheder%20for%20Communications.pdf">2024-09 Opdateret tidsplan for evaluering af strategiske muligheder for Communications.pdf</a> </li></ul>

Demant A/S: Opdateret tidsplan for evalueringen af strategiske muligheder  for Communications

Probabilities of success in drug development

Return on capital (ROE, ROI, ROIC, RONIC)

Helsinki Stock Exchange is cheap

Valuation methods: Valuation multiples

Drug development investment: Value creation through M&As and licensing agreements

Kontakter

Om Demant A/S

Vedhæftninger

Stay up to date with our newsletter